In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Valve for Life Portugal - May 2017

29 May 2017

RCTeles_photo.pngThe Portuguese country population is 10 million and ranks third place for the median age among 28 European countries, just surpassed by Germany and Italy. There are around one million individuals in Portugal with more than 75 years of age and about 4.500 have indication to TAVI due to high risk or inoperability. Moreover, if indications are expanded to intermediate risk, it is possible to forecast at least the double amount of patients in need for TAVI.

About 95% of the valvular structural activity is performed in public hospitals in a total of 5 out of 7 public centres that have permanent on-site surgical departments and run valvular heart team programmes, as currently required by the national clinical orientation norms. The clinical algorithm for transcatheter aortic valve interventions  (TAVI) follows the European Society of Cardiology Guidelines the Valvular Academic Research Consortium-2 definitions.

Until 2016 only 1200 implants were performed: TAVI procedures remained steady at around 7 per million population until 2012 and increased thereafter reching 40 per million population in the last year.

The Valve For Life Portugal is an anbitious broad plan to improve treatment of valvular disease that started to overcome patient and societal related barriers, gate keepers bias and hospital difficulties. In 2017 we expect increase both in the procedural rates of aortic valvular replacement (AVR) and TAVI, reaching a 50% incresse in valvular procedures to 60 per million population, including a significant improvement in percutaneous mitral valve repair and other valvular techniques.

Rui Campante Teles, MD, FESC
Valve for Life Champion